Polycystic Ovary Syndrome: Special Diagnostic and Therapeutic Considerations for Children

Pediatric Dermatology

Volumn 32, Issue 5, 2015, Pages 571-578

  Kamangar, Faranak ^a   Okhovat, Jean Phillip ^b   Schmidt, Timothy ^c   Beshay, Abram ^d   Pasch, Lauri ^e   Cedars, Marcelle I ^e   Huddleston, Heather ^e   Shinkai, Kanade ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANOVULATION; ARTICLE; CHILDHOOD OBESITY; EARLY INTERVENTION; ENVIRONMENT; GENETIC RISK; GENETICS; HUMAN; HYPERANDROGENISM; MENSTRUAL IRREGULARITY; NONHUMAN; OVARY POLYCYSTIC DISEASE; PRENATAL PERIOD; PRIORITY JOURNAL; ADOLESCENT; AGE; CHILD; COMORBIDITY; COMPARATIVE STUDY; DISEASE MANAGEMENT; FEMALE; INFERTILITY, FEMALE; INSULIN RESISTANCE; OBESITY; POLYCYSTIC OVARY SYNDROME; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

ADOLESCENT; AGE FACTORS; CHILD; COMORBIDITY; DISEASE MANAGEMENT; FEMALE; HUMANS; INFERTILITY, FEMALE; INSULIN RESISTANCE; OBESITY; POLYCYSTIC OVARY SYNDROME; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

EID: 84941313705     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/pde.12566     Document Type: Article

References (50)

1. Norman RJ, Dewailly D, Legro RS, et al., Polycystic ovary syndrome. Lancet 2007; 370: 685-697.
2. Archer JS, Chang RJ,. Hirsutism and acne in polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 2004; 18: 737-754.
3. Ozdemir S, Ozdemir M, Gorkemli H, et al., Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism. Acta Obstet Gynecol Scand 2010; 89: 199-204.
4. Stein LLM,. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935; 29: 181-191.
5. Knochenhauer ES, Key TJ, Kahsar-Miller M, et al., Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998; 83: 3078-3082.
6. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, et al., A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 1999; 84: 4006-4011.
7. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81: 19-25.
8. Reyss AC, Proust-Richard C, Catteau-Jonard S, et al., Rotterdam consensus in adolescent girls: which investigations and how to interpret them to make the diagnosis of PCOS? Gynecol Obstet Fertil 2006; 34: 341-346.
9. Ehrmann DA,. Polycystic ovary syndrome. N Engl J Med 2005; 352: 1223-1236.
10. Harrison CL, Lombard CB, Moran LJ, et al., Exercise therapy in polycystic ovary syndrome: a systematic review. Hum Reprod Update 2011; 17: 171-183.
11. Johnstone EB, Davis G, Zane LT, et al., Age-related differences in the reproductive and metabolic implications of polycystic ovarian syndrome: findings in an obese, United States population. Gynecol Endocrinol 2012; 28: 819-822.
12. Hashemipour M, Amini M, Iranpour R, et al., Prevalence of congenital hypothyroidism in Isfahan, Iran: results of a survey on 20,000 neonates. Horm Res 2004; 62: 79-83.
13. Driscoll DA,. Polycystic ovary syndrome in adolescence. Semin Reprod Med 2003; 21: 301-307.
14. Bronstein J, Tawdekar S, Liu Y, et al., Age of onset of polycystic ovarian syndrome in girls may be earlier than previously thought. J Pediatr Adolesc Gynecol 2011; 24: 15-20.
15. Franks S,. Polycystic ovary syndrome in adolescents. Int J Obes 2008; 32: 1035-1041.
16. Legro RS, Driscoll D, Strauss JF III, et al., Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci USA 1998; 95: 14956-14960.
17. Vink JM, Sadrzadeh S, Lambalk CB, et al., Heritability of polycystic ovary syndrome in a Dutch twin-family study. J Clin Endocrinol Metab 2006; 91: 2100-2104.
18. Azziz R,. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature. J Clin Endocrinol Metab 2006; 91: 781-785.
19. Hague WM, Adams J, Reeders ST, et al., Familial polycystic ovaries: a genetic disease? Clin Endocrinol 1988; 29: 593-605.
20. Dunaif A, Segal KR, Shelley DR, et al., Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes 1992; 41: 1257-1266.
21. Stewart DR, Dombroski BA, Urbanek M, et al., Fine mapping of genetic susceptibility to polycystic ovary syndrome on chromosome 19p13.2 and tests for regulatory activity. J Clin Endocrinol Metab 2006; 91: 4112-4117.
22. Abbott DH, Dumesic DA, Franks S,. Developmental origin of polycystic ovary syndrome-a hypothesis. J Endocrinol 2002; 174: 1-5.
23. Pasquali R, Stener-Victorin E, Yildiz BO, et al., PCOS forum: research in polycystic ovary syndrome today and tomorrow. Clin Endocrinol 2011; 74: 424-433.
24. McClamrock HD, Adashi EY,. Gestational hyperandrogenism. Fertil Steril 1992; 57: 257-274.
25. Ibanez L, Lopez-Bermejo A, Callejo J, et al., Polycystic ovaries in nonobese adolescents and young women with ovarian androgen excess: relation to prenatal growth. J Clin Endocrinol Metab 2008; 93: 196-199.
26. Barker DJ, Eriksson JG, Forsen T, et al., Fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol 2002; 31: 1235-1239.
27. Rosenfield RL,. Clinical review: identifying children at risk for polycystic ovary syndrome. J Clin Endocrinol Metab 2007; 92: 787-796.
28. Ibanez L, de Zegher F,. Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity. J Clin Endocrinol Metab 2004; 89: 1592-1597.
29. Guastella E, Longo RA, Carmina E,. Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes. Fertil Steril 2010; 94: 2197-2201.
30. Connor EL,. Adolescent polycystic ovary syndrome. Adolesc Med State Art Rev 2012; 23: 164-177.
31. Kahsar-Miller MD, Nixon C, Boots LR, et al., Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS. Fertil Steril 2001; 75: 53-58.
32. Moran C, Knochenhauer E, Boots LR, et al., Adrenal androgen excess in hyperandrogenism: relation to age and body mass. Fertil Steril 1999; 71: 671-674.
33. Bili H, Laven J, Imani B, et al., Age-related differences in features associated with polycystic ovary syndrome in normogonadotrophic oligo-amenorrhoeic infertile women of reproductive years. Eur J Endocrinol 2001; 145: 749-755.
34. Kumar A, Woods KS, Bartolucci AA, et al., Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS). Clin Endocrinol 2005; 62: 644-649.
35. Huang A, Brennan K, Azziz R,. Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria. Fertil Steril 2010; 93: 1938-1941.
36. Harper JC,. Evaluating hyperandrogenism: a challenge in acne management. J Drugs Dermatol 2008; 7: 527-530.
37. Lolis MS, Bowe WP, Shalita AR,. Acne and systemic disease. Med Clin North Am 2009; 93: 1161-1181.
38. Chen MJ, Chen CD, Yang JH, et al., High serum dehydroepiandrosterone sulfate is associated with phenotypic acne and a reduced risk of abdominal obesity in women with polycystic ovary syndrome. Hum Reprod 2011; 26: 227-234.
39. Coviello AD, Legro RS, Dunaif A,. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J Clin Endocrinol Metab 2006; 91: 492-497.
40. Thiboutot D,. Acne: hormonal concepts and therapy. Clin Dermatol 2004; 22: 419-428.
41. Ghosh S, Chaudhuri S, Jain VK, et al., Profiling and hormonal therapy for acne in women. Indian J Dermatol 2014; 59: 107-115.
42. Lucky AW, Biro FM, Daniels SR, et al., The prevalence of upper lip hair in black and white girls during puberty: a new standard. J Pediatr 2001; 138: 134-136.
43. Lujan ME, Jarrett BY, Brooks ED, et al., Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume. Hum Reprod 2013; 28: 1361-1368.
44. Venturoli S, Porcu E, Fabbri R, et al., Longitudinal change of sonographic ovarian aspects and endocrine parameters in irregular cycles of adolescence. Pediatr Res 1995; 38: 974-980.
45. Mortensen M, Rosenfield RL, Littlejohn E,. Functional significance of polycystic-size ovaries in healthy adolescents. J Clin Endocrinol Metab 2006; 91: 3786-3790.
46. Carmina E, Oberfield SE, Lobo RA,. The diagnosis of polycystic ovary syndrome in adolescents. Am J Obstet Gynecol 2010; 203: 201.e1-201.e5.
47. Sultan C, Paris F,. Clinical expression of polycystic ovary syndrome in adolescent girls. Fertil Steril 2006; 86 (Suppl 1): S6.
48. Dokras A, Witchel SF,. Are young adult women with polycystic ovary syndrome slipping through the healthcare cracks? J Clin Endocrinol Metab 2014; 99: 1583-1585.
49. Lass N, Kleber M, Winkel K, et al., Effect of lifestyle intervention on features of polycystic ovarian syndrome, metabolic syndrome, and intima-media thickness in obese adolescent girls. J Clin Endocrinol Metab 2011; 96: 3533-3540.
50. Lake JK, Power C, Cole TJ,. Women's reproductive health: the role of body mass index in early and adult life. Int J Obes Relat Metab Disord 1997; 21: 432-438.